Clik here to view.
Two with Mesothelioma Respond to New Therapy Combo Using Lurbinectedin
A new mesothelioma treatment based on the marine-derived drug lurbinectedin showed promising results in a preliminary study in two patients who had previously failed to respond to conventional therapy....
View ArticleClik here to view.
Yondelis Combined with Chemotherapy May Be Promising Mesothelioma Therapy...
Yondelis (trabectedin), an anti-tumor drug approved for the treatment of advanced soft tissue sarcoma and ovarian cancer, has shown promising results in malignant pleural mesothelioma (MPM) cells,...
View ArticleClik here to view.
Yondelis, Derived from Sea Cucumber, Shows Promise for Malignant Pleural...
Yondelis (trabectedin), a drug derived from the Caribbean Sea cucumber, has shown promise for treating malignant pleural mesothelioma (MPM), according to a new study published in Molecular Cancer...
View ArticleClik here to view.
Yondelis Stabilized Mesothelioma in Many Patients Taking Part in Phase 2...
Yondelis (trabectedin) stabilized a form of advanced mesothelioma that had progressed after earlier chemotherapy, according to a Phase 2 clinical trial in Italy. Researchers will present the trial’s...
View ArticleYondelis Stabilized Mesothelioma in Many Patients Taking Part in Phase 2...
Yondelis (trabectedin) stabilized a form of advanced mesothelioma that had progressed after earlier chemotherapy, according to a Phase 2 clinical trial in Italy. Researchers will present the trial’s...
View Article
